SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-039115
Filing Date
2020-06-26
Accepted
2020-06-26 17:10:50
Documents
2
Period of Report
2020-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7037
2 POA DOCUMENT poa.txt EX-24.3_924760 3971
  Complete submission text file 0001209191-20-039115.txt   12428
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005
Business Address
Ciulla Thomas (Reporting) CIK: 0001815426 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37783 | Film No.: 20995022